Literature DB >> 22570121

Hearing preservation in patients with unilateral vestibular schwannoma who undergo stereotactic radiosurgery: Reinterpretation of the auditory brainstem response.

Jung Ho Han1, Dong Gyu Kim, Hyun-Tai Chung, Sun Ha Paek, Chul-Kee Park, Chae-Yong Kim, Young-Hoon Kim, Jin Wook Kim, Yong Hwy Kim, Sang Woo Song, In Kyung Kim, Hee-Won Jung.   

Abstract

BACKGROUND: The objective of this study was to identify the prognostic factors for hearing preservation that would allow the more accurate stratification of patients who undergo stereotactic radiosurgery (SRS) for unilateral, sporadic vestibular schwannoma (VS).
METHODS: In total, 119 patients with VS who had serviceable hearing underwent SRS as primary treatment. The mean (±standard deviation) patient age was 48 ± 11 years, and the mean (±standard deviation) follow-up duration was 55.2 ± 35.7 months. The median marginal radiotherapy dose was 12.0 grays (Gy), and the mean (±standard deviation) tumor volume was 1.95 ± 2.24 cm(3) . The mean (±standard deviation) pure tone average (PTA) score was 26 ± 12 decibels (dB) (range, 4-50 dB), and the mean (±standard deviation) maximum speech discrimination score was 91 ± 12% (range, 52-100%). The mean (±standard deviation) baseline values for the interlatency (IL) of waves I and III (IL I-III) and the IL of waves I through V (IL I-V) on auditory brainstem response were 2.58 ± 0.60 milliseconds (mS) (range, 1.92-4.30 mS) and 4.80 ± 0.61 mS (range, 3.80-6.40 mS), respectively.
RESULTS: In multivariate analysis, the PTA score and IL I-V were significant and independent prognostic factors (hazard ratio, 1.072; 95% confidence interval, 1.046-1.098; P < .001; and hazard ratio, 1.534; 95% confidence interval, 1.008-2.336; P = .046, respectively). By using the PTA score and IL I-V, the patients were classified into 4 groups. The ratios of patients with serviceable hearing after SRS were 89.6%, 64.0%, 25.8%, and 6.7%, respectively, in Groups A through D (P < .001).
CONCLUSIONS: The current results indicated that the classification system based on using the PTA score and the IL I-V of the auditory brainstem response may be useful and specific for predicting the rate of hearing preservation in each individual.
Copyright © 2012 American Cancer Society.

Entities:  

Mesh:

Year:  2012        PMID: 22570121     DOI: 10.1002/cncr.27501

Source DB:  PubMed          Journal:  Cancer        ISSN: 0008-543X            Impact factor:   6.860


  5 in total

1.  Modern Gamma Knife radiosurgery of vestibular schwannomas: treatment concept, volumetric tumor response, and functional results.

Authors:  Samuel M Lipski; Motohiro Hayashi; Mikhail Chernov; Marc Levivier; Yoshikazu Okada
Journal:  Neurosurg Rev       Date:  2014-12-19       Impact factor: 3.042

2.  Systematic Review of Hearing Preservation After Radiotherapy for Vestibular Schwannoma.

Authors:  Adam R Coughlin; Tyler J Willman; Samuel P Gubbels
Journal:  Otol Neurotol       Date:  2018-03       Impact factor: 2.311

3.  Stereotactic radiosurgery for vestibular schwannoma: International Stereotactic Radiosurgery Society (ISRS) Practice Guideline.

Authors:  May N Tsao; Arjun Sahgal; Wei Xu; Antonio De Salles; Motohiro Hayashi; Marc Levivier; Lijun Ma; Roberto Martinez; Jean Régis; Sam Ryu; Ben J Slotman; Ian Paddick
Journal:  J Radiosurg SBRT       Date:  2017

4.  Hearing Preservation after Low-dose Gamma Knife Radiosurgery of Vestibular Schwannomas.

Authors:  Ayako Horiba; Motohiro Hayashi; Mikhail Chernov; Takakazu Kawamata; Yoshikazu Okada
Journal:  Neurol Med Chir (Tokyo)       Date:  2016-02-15       Impact factor: 1.742

5.  Treatment Outcomes and Dose Rate Effects Following Gamma Knife Stereotactic Radiosurgery for Vestibular Schwannomas.

Authors:  Deborah Ruth Smith; Heva Jasmine Saadatmand; Cheng-Chia Wu; Paul J Black; Yen-Ruh Wuu; Jeraldine Lesser; Maryellen Horan; Steven R Isaacson; Tony J C Wang; Michael B Sisti
Journal:  Neurosurgery       Date:  2019-12-01       Impact factor: 4.654

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.